Brown NJ - Search Results

1

Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry.

Daniel VC, Minton TA, Brown NJ, Nadeau JH, Morrow JD. Daniel VC, et al. Among authors: brown nj. J Chromatogr B Biomed Appl. 1994 Mar 4;653(2):117-22. doi: 10.1016/0378-4347(93)e0432-p. J Chromatogr B Biomed Appl. 1994. PMID: 8205238

2

Does race predispose to angiotensin-associated angioneurotic edema?

Brown NJ, Nadeau JH. Brown NJ, et al. Ann Intern Med. 1993 Dec 15;119(12):1224. doi: 10.7326/0003-4819-119-12-199312150-00020. Ann Intern Med. 1993. PMID: 8239260 No abstract available.

3

Caffeine attenuates the renal vascular response to angiotensin II infusion.

Brown NJ, Ryder D, Nadeau J. Brown NJ, et al. Hypertension. 1993 Dec;22(6):847-52. doi: 10.1161/01.hyp.22.6.847. Hypertension. 1993. PMID: 8244516

4

Increased sensitivity to bradykinin among African Americans.

Gainer JV, Nadeau JH, Ryder D, Brown NJ. Gainer JV, et al. Among authors: brown nj. J Allergy Clin Immunol. 1996 Aug;98(2):283-7. doi: 10.1016/s0091-6749(96)70151-3. J Allergy Clin Immunol. 1996. PMID: 8757204 Clinical Trial.

5

Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.

Brown NJ, Ryder D, Gainer JV, Morrow JD, Nadeau J. Brown NJ, et al. J Pharmacol Exp Ther. 1996 Nov;279(2):703-12. J Pharmacol Exp Ther. 1996. PMID: 8930174 Clinical Trial.

6

Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.

Brown NJ, Nadeau JH, Vaughan DE. Brown NJ, et al. Thromb Haemost. 1997 Mar;77(3):522-5. Thromb Haemost. 1997. PMID: 9066005 Clinical Trial.

7

Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant.

Gainer JV, Hunley TE, Kon V, Nadeau JH, Muldowney JA 3rd, Brown NJ. Gainer JV, et al. Among authors: brown nj. Biochem Mol Biol Int. 1997 Sep;43(1):227-31. doi: 10.1080/15216549700204001. Biochem Mol Biol Int. 1997. PMID: 9315301

8

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ. Gainer JV, et al. Among authors: brown nj. N Engl J Med. 1998 Oct 29;339(18):1285-92. doi: 10.1056/NEJM199810293391804. N Engl J Med. 1998. PMID: 9791144 Free article. Clinical Trial.

9

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.

Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE. Brown NJ, et al. J Clin Endocrinol Metab. 2000 Jan;85(1):336-44. doi: 10.1210/jcem.85.1.6305. J Clin Endocrinol Metab. 2000. PMID: 10634408 Clinical Trial.

10

Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite.

Murphey LJ, Hachey DL, Oates JA, Morrow JD, Brown NJ. Murphey LJ, et al. Among authors: brown nj. J Pharmacol Exp Ther. 2000 Jul;294(1):263-9. J Pharmacol Exp Ther. 2000. PMID: 10871321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

866 results

Search Page

Filters